888-776-0942 from 8 AM - 10 PM ET
NEW YORK , Sept. 26, 2022 /PRNewswire/ -- The global ophthalmology devices market has been categorized as a part of the global healthcare equipment market. The parent market, the global healthcare equipment market, covers products and companies engaged in the R&D of a variety of product categories, including capital equipment, instruments, implants, accessories, and consumables that are used for the diagnosis, monitoring, and treatment of various diseases.
The ophthalmology devices market size is expected to grow by USD 17.09 billion from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 4.1% during the forecast period, according to Technavio.
The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. Request Latest FREE PDF Sample Report
Ophthalmology Devices Market 2022-2026: Scope
The ophthalmology devices market report covers the following areas:
Ophthalmology Devices Market 2022-2026: Vendor Landscape
The ophthalmology devices market is fragmented. Vendors are deploying growth strategies such as organic and inorganic strategies to compete in the market. The market has several major market players. Prominent vendors are developing new devices with upgraded technologies to compete with existing vendors in the market. Some vendors are entering into partnerships to establish their market position globally. The competition in the market will intensify, with the rise in the number of ophthalmic disorders. Vendors are investing in developing customized solutions to expand their foothold in the market.
AbbVie Inc., Alcon Inc., Bausch Health Co. Inc., Carl Zeiss AG, Danaher Corp., Digital Diagnostics Inc., EssilorLuxottica, EyeQue Corp., Glaukos Corp, HOYA Corp., IRIDEX Corp., Johnson and Johnson, LENSAR Inc., Lumenis Ltd., LUMIBIRD SA, Metall Zug AG, NIDEK Co. Ltd, STAAR Surgical Co., The Cooper Companies Inc., and Ziemer Ophthalmic Systems AG are among some of the major market participants.
Ophthalmology Devices Market 2022-2026: Segmentation
Ophthalmology Devices Market 2022-2026: Revenue-generating Product Segments
The vision care segment will be the largest contributor to market growth during the forecast period. Spectacle lenses that are made of high-tech plastics are more resistant to scratches than conventional plastics. In addition, high-definition (HD) spectacle lenses can be customized for individuals. Thus, the rising investments in marketing and product promotions by vendors are driving the market growth.
Ophthalmology Devices Market 2022-2026: Regional Analysis
North America will account for 42% of the market's growth during the forecast period. The growth of this region is attributed to factors such as the increasing healthcare expenditure on ocular diseases, the rising number of product approvals, and the growing adoption of technologically advanced ophthalmology devices. Moreover, market growth in this region will be slower than the growth of the market in other regions. The US is the key country for the ophthalmology devices market in North America .
Learn about the contribution of each region summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report
Ophthalmology Devices Market 2022-2026: Key Highlights
Ophthalmology Surgical Devices Market by Product and Geography - Forecast and Analysis 2022-2026: The ophthalmology surgical devices market share is expected to increase by USD 3.13 billion from 2021 to 2026.
Synoptophore Market by Application and Geography - Forecast and Analysis 2022-2026: The synoptophore market share is expected to increase by USD 62.28 million from 2021 to 2026.
Accelerate at a CAGR of 4.1%
North America, Europe, Asia, and Rest of World (ROW)
US, Canada, Germany, UK, and China
Leading companies, competitive strategies, consumer engagement scope
AbbVie Inc., Alcon Inc., Bausch Health Co. Inc., Carl Zeiss AG, Danaher Corp., Digital Diagnostics Inc., EssilorLuxottica, EyeQue Corp., Glaukos Corp, HOYA Corp., IRIDEX Corp., Johnson and Johnson, LENSAR Inc., Lumenis Ltd., LUMIBIRD SA, Metall Zug AG, NIDEK Co. Ltd, STAAR Surgical Co., The Cooper Companies Inc., and Ziemer Ophthalmic Systems AG
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Browse Health Care Market Reports
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: www.technavio.com/
More news releases in similar topics
Cision Distribution 888-776-0942 from 8 AM - 9 PM ET